申请人:Purdue Pharmaceutical Products L.P.
公开号:US20140303218A1
公开(公告)日:2014-10-09
The disclosure includes compounds of Formula (1): wherein X
1
, X
2
, Q, Z, R
1
, and R
2
are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
该公开涵盖了Formula (1)的化合物:其中X1、X2、Q、Z、R1和R2在此处定义。还公开了使用这些化合物治疗肿瘤性疾病或免疫性疾病的方法。